Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3190) 3190
Book Review (457) 457
Publication (116) 116
Newsletter (40) 40
Magazine Article (18) 18
Book Chapter (10) 10
Newspaper Article (10) 10
Conference Proceeding (4) 4
Government Document (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2759) 2759
humans (2442) 2442
female (1496) 1496
clindamycin - administration & dosage (1347) 1347
male (1255) 1255
clindamycin (1241) 1241
adult (1077) 1077
clindamycin - therapeutic use (1075) 1075
anti-bacterial agents - administration & dosage (799) 799
anti-bacterial agents - therapeutic use (770) 770
middle aged (730) 730
adolescent (579) 579
abridged index medicus (569) 569
antibiotics (551) 551
animals (479) 479
drug therapy, combination (474) 474
aged (442) 442
treatment outcome (441) 441
infectious diseases (384) 384
pharmacology & pharmacy (367) 367
clindamycin - adverse effects (361) 361
child (360) 360
administration, oral (359) 359
microbiology (332) 332
clindamycin - pharmacology (328) 328
acne vulgaris - drug therapy (326) 326
dermatology (309) 309
anti-bacterial agents - pharmacology (279) 279
infections (272) 272
microbial sensitivity tests (261) 261
prospective studies (253) 253
drug therapy (248) 248
dosage and administration (239) 239
administration, topical (238) 238
pregnancy (232) 232
health aspects (226) 226
anti-bacterial agents - adverse effects (224) 224
therapy (208) 208
bacterial infections - drug therapy (206) 206
care and treatment (205) 205
surgery (204) 204
acne (203) 203
risk factors (203) 203
drug combinations (202) 202
young adult (202) 202
drug administration schedule (192) 192
child, preschool (191) 191
double-blind method (191) 191
gentamicins - administration & dosage (187) 187
research (180) 180
infection (178) 178
time factors (175) 175
bacteria (170) 170
efficacy (160) 160
erythromycin (159) 159
medicine, general & internal (159) 159
retrospective studies (158) 158
metronidazole (157) 157
staphylococcal infections - drug therapy (151) 151
children (148) 148
clindamycin - analogs & derivatives (145) 145
clinical trials as topic (145) 145
pediatrics (142) 142
dentistry (140) 140
surgical wound infection - prevention & control (139) 139
drug resistance (137) 137
obstetrics & gynecology (137) 137
benzoyl peroxide (135) 135
management (135) 135
benzoyl peroxide - administration & dosage (133) 133
injections, intravenous (133) 133
gentamicins - therapeutic use (132) 132
analysis (131) 131
infant (129) 129
diagnosis (127) 127
antibacterial agents (126) 126
immunology (126) 126
skin (126) 126
follow-up studies (125) 125
vaginosis, bacterial - drug therapy (125) 125
aged, 80 and over (124) 124
staphylococcus aureus (122) 122
mice (121) 121
gels (118) 118
administration, cutaneous (117) 117
penicillin (116) 116
vancomycin (116) 116
double-blind (114) 114
drug resistance in microorganisms (114) 114
bacterial vaginosis (113) 113
clindamycin - pharmacokinetics (112) 112
severity of illness index (112) 112
metronidazole - therapeutic use (111) 111
antimicrobial agents (109) 109
antibiotic prophylaxis (106) 106
random allocation (105) 105
dermatologic agents - administration & dosage (104) 104
medicine & public health (104) 104
prevention (103) 103
drug resistance, bacterial (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2999) 2999
German (59) 59
Japanese (56) 56
French (42) 42
Spanish (35) 35
Italian (17) 17
Russian (11) 11
Polish (7) 7
Dutch (6) 6
Hungarian (5) 5
Portuguese (5) 5
Bulgarian (4) 4
Danish (4) 4
Chinese (2) 2
Swedish (2) 2
Croatian (1) 1
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text In Vivo Bioluminescence Imaging To Evaluate Systemic and Topical Antibiotics against Community-Acquired Methicillin-Resistant Staphylococcus aureus-Infected Skin Wounds in Mice
by Yi Guo and Romela Irene Ramos and John S. Cho and Niles P. Donegan and Ambrose L. Cheung and Lloyd S. Miller
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 855 - 863
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
SOFT-TISSUE INFECTIONS | DOSE PHARMACOKINETICS | CLINICAL-TRIAL | ANTIBACTERIAL ACTIVITY | MOUSE MODEL | ECONOMIC OUTCOMES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | LENGTH-OF-STAY | MURINE THIGH INFECTION | COMPLICATED SKIN | TRIMETHOPRIM-SULFAMETHOXAZOLE | Linezolid | Skin - microbiology | Mupirocin - administration & dosage | Male | Luminescent Measurements | Mupirocin - therapeutic use | Oxazolidinones - administration & dosage | Skin - injuries | Oxazolidinones - therapeutic use | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Staphylococcal Skin Infections - drug therapy | Acetamides - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Clindamycin - administration & dosage | Community-Acquired Infections - drug therapy | Diabetes Mellitus, Type 2 | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Wound Healing - drug effects | Daptomycin - therapeutic use | Disease Models, Animal | Staphylococcal Infections - drug therapy | Vancomycin - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Administration, Oral | Doxycycline - therapeutic use | Methicillin-Resistant Staphylococcus aureus - drug effects | Mice, Inbred C57BL | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Bacterial Load | Clindamycin - therapeutic use | Animals | Soft Tissue Infections - microbiology | Vancomycin - therapeutic use | Mice | Administration, Topical | Anti-Bacterial Agents - administration & dosage | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Daptomycin - administration & dosage | Acetamides - administration & dosage | Index Medicus | Animal models | Bioluminescence | Intravenous administration | Image processing | Clindamycin | Vancomycin | Cellulitis | Drug resistance | Polyethylene glycol | Surgery | daptomycin | Ointments | Wound infection | Wound healing | Diabetes mellitus | Antimicrobial agents | Folliculitis | Mupirocin | imaging | Soft tissues | Drainage | Photography | Antibiotics | trimethoprim-sulfamethoxazole | Ulcers | Doxycycline | Impetigo | Skin | Experimental Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Long-term ecological impacts of antibiotic administration on the human intestinal microbiota
by Jernberg, Cecilia and Löfmark, Sonja and Edlund, Charlotta and Jansson, Janet K
The ISME Journal, ISSN 1751-7362, 05/2007, Volume 1, Issue 1, pp. 56 - 66
Antibiotic administration is known to cause short-term disturbances in the microbiota of the human gastrointestinal tract, but the potential long-term... 
Clindamycin | T-RFLP | Faeces | Rep-PCR | Bacteroides | BACTERIA | FECAL MICROBIOTA | GUT | GRADIENT GEL-ELECTROPHORESIS | HUMAN FECES | rep-PCR | REAL-TIME PCR | BACTEROIDES-FRAGILIS | RESISTANCE GENES | faeces | ECOLOGY | POLYMERASE CHAIN-REACTION | clindamycin | 16S RIBOSOMAL-RNA | Intestines - drug effects | Genes, Bacterial - genetics | Humans | Bacteria - drug effects | Methyltransferases - genetics | Male | Genetic Variation | Feces - microbiology | Clindamycin - adverse effects | Time Factors | Clindamycin - administration & dosage | Ecosystem | Polymerase Chain Reaction | Adult | Capsules - administration & dosage | Female | Anti-Bacterial Agents - adverse effects | Drug Resistance, Bacterial - genetics | Administration, Oral | Bacterial Proteins - genetics | Bacteria - genetics | Bacteroides - drug effects | Bacteroides - genetics | Bacteria - isolation & purification | Intestines - microbiology | Polymorphism, Restriction Fragment Length | Anti-Bacterial Agents - administration & dosage | Bacteroides - isolation & purification | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Recurrence of Bacterial Vaginosis Is Significantly Associated With Posttreatment Sexual Activities and Hormonal Contraceptive Use
by Catriona S. Bradshaw and Lenka A. Vodstrcil and Jane S. Hocking and Matthew Law and Marie Pirotta and Suzanne M. Garland and Deborah De Guingand and Anna N. Morton and Christopher K. Fairley
Clinical Infectious Diseases, ISSN 1058-4838, 3/2013, Volume 56, Issue 6, pp. 777 - 786
Background. Bacterial vaginosis (BV) recurrence posttreatment is common. Our aim was to determine if behaviors were associated with BV recurrence in women in a... 
Bacterial vaginosis | Human sexual behavior | Birth control | Medical practice | Flora | Womens health | Contraception | Condoms | ARTICLES AND COMMENTARIES | Sexual partners | Oral sex | sexual partner | estrogen | condom use | bacterial vaginosis | contraceptive use | GARDNERELLA-VAGINALIS | INFECTIOUS DISEASES | RISK | MICROBIOLOGY | LACTOBACILLI | COLONIZATION | IMMUNOLOGY | PARTNERS | WOMEN | VAGINAL FLORA | HYDROGEN-PEROXIDE | ORAL METRONIDAZOLE | METRONIDAZOLE PLUS | Probiotics - administration & dosage | Recurrence | Sexual Behavior | Double-Blind Method | Administration, Oral | Contraceptive Agents - administration & dosage | Humans | Metronidazole - administration & dosage | Middle Aged | Risk Factors | Administration, Intravaginal | Australia - epidemiology | Vaginosis, Bacterial - drug therapy | Young Adult | Anti-Infective Agents - administration & dosage | Clindamycin - administration & dosage | Adolescent | Adult | Female | Vaginosis, Bacterial - epidemiology | Placebos - administration & dosage | Women | Care and treatment | Contraceptives | Usage | Relapse | Health aspects | Risk factors | Vaginosis | Diseases | Bacterial infections | Estrogen | Clinical trials | Index Medicus | Inventories | Clindamycin | Vagina | Data processing | Metronidazole | probiotics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Dosing antibiotics in neonates: Review of the pharmacokinetic data
by Rivera-Chaparro, Nazario D and Cohen-Wolkowiez, Michael and Greenberg, Rachel G
Future Microbiology, ISSN 1746-0913, 09/2017, Volume 12, Issue 11, pp. 1001 - 1016
Antibiotics are often used in neonates despite the absence of relevant dosing information in drug labels. For neonatal dosing, clinicians must extrapolate data... 
aminoglycoside | β-lactams | drug dosing | carbapenem | anti-infective agents | pharmacokinetics | preterm | neonate | infant | cephalosporins | INTRAVENOUS METRONIDAZOLE | GLOMERULAR-FILTRATION | SCAVENGED SAMPLES | PREMATURE-INFANTS | MICROBIOLOGY | DEVELOPMENTAL PHARMACOKINETICS | CEFTAZIDIME PHARMACOKINETICS | beta-lactams | STAPHYLOCOCCUS-AUREUS INFECTIONS | POPULATION PHARMACOKINETICS | TISSUE DISTRIBUTION | CLINICAL-PRACTICE | beta-Lactams - pharmacokinetics | Birth Weight - drug effects | Glycopeptides - administration & dosage | Humans | Thienamycins - pharmacokinetics | Infant | Clindamycin - pharmacokinetics | Piperacillin - administration & dosage | Clindamycin - adverse effects | Aminoglycosides - administration & dosage | Clindamycin - administration & dosage | Metronidazole - adverse effects | Adult | Anti-Bacterial Agents - adverse effects | Glycopeptides - pharmacokinetics | Infant, Newborn - physiology | Thienamycins - adverse effects | Child | Penicillanic Acid - analogs & derivatives | Penicillanic Acid - administration & dosage | Body Size - drug effects | Medication Reconciliation | Thienamycins - administration & dosage | Aminoglycosides - pharmacokinetics | Metronidazole - administration & dosage | Cephalosporins - administration & dosage | Glycopeptides - adverse effects | Metronidazole - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | beta-Lactams - adverse effects | Aminoglycosides - adverse effects | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Index Medicus
Journal Article
Details down arrow
5. Full Text Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection
by Ronen Ben-Ami and Keren Olshtain-Pops and Michal Krieger and Ilana Oren and Jihad Bishara and Michael Dan and Yonit Wiener-Well and Miriam Weinberger and Oren Zimhony and Michal Chowers and Gabriel Weber and Israel Potasman and Bibiana Chazan and Imad Kassis and Itamar Shalit and Colin Block and Nathan Keller and Dimitrios P. Kontoyiannis and Michael Giladi and for the Israeli Candidemia Study Group and Israeli Candidemia Study Grp and Israeli Candidemia Study Group and for the Israeli Candidemia Study Group
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2012, Volume 56, Issue 5, pp. 2518 - 2523
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CHANGING EPIDEMIOLOGY | GLABRATA | THERAPY | ANTIFUNGAL AGENTS | NEUTROPHILS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | COLONIZATION | SULFAMETHOXAZOLE | OUTCOMES | ALBICANS | KRUSEI | Candida glabrata - physiology | Coinfection | Prospective Studies | Carbapenems - administration & dosage | Humans | Middle Aged | Bacteria - drug effects | Fluconazole - administration & dosage | Candidiasis - microbiology | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Bacteria - growth & development | Clindamycin - adverse effects | Candidiasis - drug therapy | Clindamycin - administration & dosage | Aged, 80 and over | Adult | Female | Anti-Bacterial Agents - adverse effects | Colistin - adverse effects | Odds Ratio | Drug Resistance, Fungal | Bacterial Infections - microbiology | Candidemia - microbiology | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Bacterial Infections - drug therapy | Risk Factors | Colistin - administration & dosage | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Carbapenems - adverse effects | Candidiasis - etiology | Candidemia - drug therapy | Aged | Israel | Anti-Bacterial Agents - administration & dosage | Antifungal Agents - administration & dosage | Candidemia - etiology | Candida glabrata - drug effects | Index Medicus | Drugs | Colistin | Clindamycin | Drug resistance | Risk factors | Infection | Antibiotics | azoles | trimethoprim-sulfamethoxazole | Models | Candidemia | Metronidazole | Carbapenems | Epidemiology and Surveillance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Determining the long-term effect of antibiotic administration on the human normal intestinal microbiota using culture and pyrosequencing methods
by Rashid, M.-U and Zaura, E and Buijs, M.J and Keijser, B.J.F and Crielaard, W and Nord, C.E and Weintraub, A
Clinical infectious diseases, ISSN 1058-4838, 2015, Volume 60, Issue Suppl 2, pp. S77 - S84
The purpose of the study was to assess the effect of ciprofloxacin (500 mg twice daily for 10 days) or clindamycin (150 mg 4 times daily for 10 days) on the... 
intestinal microbiota | pyrosequencing | antibiotics | culture | COLORECTAL SURGERY | HUMAN COLON | CLOSTRIDIUM-DIFFICILE INFECTION | MICROFLORA | INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | COMMUNITY | FLUOROQUINOLONES | DISEASE | RESISTANCE | SPECTRUM | CIPROFLOXACIN | Humans | Middle Aged | Male | Clostridium difficile - isolation & purification | Colony Count, Microbial | Healthy Volunteers | Clindamycin - pharmacology | Young Adult | Feces - microbiology | Bacteria - growth & development | Time Factors | Clindamycin - administration & dosage | Bacteria - classification | Placebos | Adult | Female | RNA, Ribosomal, 16S | Ciprofloxacin - pharmacology | Gastrointestinal Tract - microbiology | Bacterial Load | Clostridium difficile - pathogenicity | Bacteria - isolation & purification | Gastrointestinal Microbiome - drug effects | Ciprofloxacin - administration & dosage | Adolescent | Anti-Bacterial Agents - pharmacology | High-Throughput Nucleotide Sequencing | Anti-Bacterial Agents - administration & dosage | Antibiotics | Bacteria | Infectious diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Long‐term administration of oral macrolides for acne treatment increases macrolide‐resistant Propionibacterium acnes
by Nakase, Keisuke and Okamoto, Yuhei and Aoki, Sae and Noguchi, Norihisa
The Journal of Dermatology, ISSN 0385-2407, 03/2018, Volume 45, Issue 3, pp. 340 - 343
Macrolide‐resistant Propionibacterium acnes are frequently isolated from patients with acne vulgaris, and the most resistant isolates (>90% resistance) have... 
acne vulgaris | long‐term administration | oral macrolides | Propionibacterium acnes | macrolide‐clindamycin resistance | macrolide-clindamycin resistance | long-term administration | ANTIMICROBIAL SUSCEPTIBILITY | IN-VITRO | INFECTIONS | MUTANTS | JAPAN | RIBOSOMAL-RNA MUTATION | DERMATOLOGY | Humans | Propionibacterium acnes - physiology | Acne Vulgaris - drug therapy | Clarithromycin - therapeutic use | RNA, Ribosomal, 23S - drug effects | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | RNA, Ribosomal, 23S - genetics | Mutation - drug effects | Long-Term Care - methods | Propionibacterium acnes - isolation & purification | Anti-Bacterial Agents - pharmacology | Drug Resistance, Bacterial - genetics | Clarithromycin - pharmacology | Acne Vulgaris - microbiology | Antiacne agents | Drug resistance in microorganisms | Drug therapy | Antibacterial agents | Acne | Clarithromycin | Clindamycin | rRNA | rRNA 23S | Antimicrobial agents | Mutation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Randomized Trial of Intravitreal Clindamycin and Dexamethasone versus Pyrimethamine, Sulfadiazine, and Prednisolone in Treatment of Ocular Toxoplasmosis
by Soheilian, Masoud, MD and Ramezani, Alireza, MD and Azimzadeh, Ahmad, MD and Sadoughi, Mohammad Mehdi, MD and Dehghan, Mohammad H., MD and Shahghadami, Reza, MS and Yaseri, Mehdi, PhD and Peyman, Gholam A., MD
Ophthalmology, ISSN 0161-6420, 2011, Volume 118, Issue 1, pp. 134 - 141
Purpose To compare the efficacy of intravitreal injection of clindamycin and dexamethasone with classic treatment for ocular toxoplasmosis. Design Prospective,... 
Ophthalmology | UVEITIS | OPHTHALMOLOGY | THERAPY | MANAGEMENT | RETINOCHOROIDITIS | MANIFESTATIONS | Single-Blind Method | Glucocorticoids - administration & dosage | Dexamethasone - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Enzyme-Linked Immunosorbent Assay | Intravitreal Injections | Humans | Male | Treatment Outcome | Toxoplasmosis, Ocular - immunology | Young Adult | Antibodies, Protozoan - blood | Immunoglobulin M - blood | Sulfadiazine - administration & dosage | Pyrimethamine - administration & dosage | Clindamycin - administration & dosage | Antiprotozoal Agents - administration & dosage | Adult | Female | Toxoplasmosis, Ocular - drug therapy | Drug Therapy, Combination | Visual Acuity - physiology | Sulfadiazine | Care and treatment | Toxoplasmosis, Ocular | Dexamethasone | Clindamycin | Central nervous system depressants | Clinical trials | Universities and colleges | Prednisolone | Steroids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Osteonecrosis After Administration of Intravitreous Bevacizumab
by Hopp, Renato Nicolás, DDS, MSc and Pucci, Juliana and Santos-Silva, Alan Roger, DDS, MSc, PhD and Jorge, Jacks, DDS, MSc, PhD
Journal of Oral and Maxillofacial Surgery, ISSN 0278-2391, 2012, Volume 70, Issue 3, pp. 632 - 635
Surgery | JAW | AVASTIN | ANGIOGENESIS | SAFETY | DENTISTRY, ORAL SURGERY & MEDICINE | MACULAR DEGENERATION | RETINA | Antibodies, Monoclonal, Humanized - adverse effects | Mouthwashes | Intravitreal Injections | Humans | Middle Aged | Male | Treatment Outcome | Osteonecrosis - pathology | Anti-Infective Agents, Local | Bevacizumab | Clindamycin - therapeutic use | Jaw Diseases - chemically induced | Anti-Bacterial Agents - therapeutic use | Angiogenesis Inhibitors - administration & dosage | Osteonecrosis - drug therapy | Antibodies, Monoclonal, Humanized - administration & dosage | Jaw Diseases - pathology | Chlorhexidine - administration & dosage | Osteonecrosis - chemically induced | Drug Therapy, Combination | Angiogenesis Inhibitors - adverse effects | Jaw Diseases - drug therapy | Antimitotic agents | Antineoplastic agents | Angiogenesis inhibitors | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis
by Dayer, Mark J, PhD and Jones, Simon, Prof and Prendergast, Bernard, FRCP and Baddour, Larry M, Prof and Lockhart, Peter B, Prof and Thornhill, Martin H, Prof
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9974, pp. 1219 - 1228
Summary Background Antibiotic prophylaxis given before invasive dental procedures in patients at risk of developing infective endocarditis has historically... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IMPACT | DENTAL PROCEDURES | BACTEREMIA | NICE GUIDANCE | GUIDELINES | PREVENTION | RISK | TEMPORAL TRENDS | AMERICAN-HEART-ASSOCIATION | ANTIBIOTIC-PROPHYLAXIS | Endocarditis - etiology | Interrupted Time Series Analysis | Administration, Oral | Humans | Middle Aged | Dental Care - adverse effects | Male | Endocarditis - epidemiology | Incidence | Drug Prescriptions - statistics & numerical data | Clindamycin - administration & dosage | Endocarditis - prevention & control | England - epidemiology | Adult | Antibiotic Prophylaxis - trends | Female | Aged | Amoxicillin - administration & dosage | Retrospective Studies | Anti-Bacterial Agents - administration & dosage | Antibiotic Prophylaxis - utilization | Practice Guidelines as Topic | Infective endocarditis | Analysis | Heart | Disease prevention | Medical research | Biomedical research | Antibiotics | Dental surgery | Mortality | Cardiovascular disease | Cardiology | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Oral ofloxacin and clindamycin as an alternative to the classic rifampicin–clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients
by Delaunay, J and Villani, A.P and Guillem, P and Tristan, A and Boibieux, A and Jullien, D
British Journal of Dermatology, ISSN 0007-0963, 01/2018, Volume 178, Issue 1, pp. e15 - e16
Drug Administration Schedule | Administration, Oral | Humans | Middle Aged | Hidradenitis Suppurativa - drug therapy | Male | Treatment Outcome | Dose-Response Relationship, Drug | Young Adult | Clindamycin - administration & dosage | Adolescent | Ofloxacin - administration & dosage | Adult | Female | Retrospective Studies | Rifampin - administration & dosage | Drug Substitution | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Child | PROGESTERONE | PREGNANCY | DERMATOLOGY | Ofloxacin | Rifampin | Analysis | Clindamycin | Index Medicus | Life Sciences | Microbiology and Parasitology | Immunology | Bacteriology | Virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug‐outcome associations: The case of clindamycin and Clostridium difficile infection
by Carnahan, Ryan M and Kuntz, Jennifer L and Wang, Shirley V and Fuller, Candace and Gagne, Joshua J and Leonard, Charles E and Hennessy, Sean and Meyer, Tamra and Archdeacon, Patrick and Chen, Chih‐Ying and Panozzo, Catherine A and Toh, Sengwee and Katcoff, Hannah and Woodworth, Tiffany and Iyer, Aarthi and Axtman, Sophia and Chrischilles, Elizabeth A
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 07/2018, Volume 27, Issue 7, pp. 731 - 739
Purpose: The Food and Drug Administration's Sentinel System developed parameterized, reusable analytic programs for evaluation of medical product safety.... 
postmarketing | Clostridium difficile | product surveillance | clindamycin | penicillins | United States Food and Drug Administration | pharmacoepidemiology | Pharmacoepidemiology | Postmarketing | Clindamycin | Penicillins | Product surveillance | ANTIBIOTICS | RISK-FACTORS | METAANALYSIS | DIARRHEA | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | DISEASE | PHARMACOLOGY & PHARMACY | COHORT | EPIDEMIC | Health aspects | Penicillin | Medical research | Evaluation | Statistical analysis | Identification methods | Sentinel system | Hazards | Infections | Exposure | Regression analysis | Convergence | Matching | Confidence intervals | Antibiotics | Bacteria | Product safety | Food
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?
by Mendes‐Bastos, P and Macedo, R and Duarte, R
British Journal of Dermatology, ISSN 0007-0963, 10/2017, Volume 177, Issue 4, pp. e150 - e151
ORAL CLINDAMYCIN | FOLLOW | COMBINATION THERAPY | DERMATOLOGY | Antibiotics, Antitubercular - adverse effects | Drug Administration Schedule | Humans | Hidradenitis Suppurativa - drug therapy | Contraindications, Drug | Moxifloxacin | Fluoroquinolones - adverse effects | Clindamycin - adverse effects | Rifampin - adverse effects | Mycobacterium tuberculosis | Clindamycin - administration & dosage | Tuberculosis, Multidrug-Resistant - prevention & control | Anti-Bacterial Agents - adverse effects | Rifampin - administration & dosage | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Antibiotics, Antitubercular - administration & dosage | Fluoroquinolones - administration & dosage | Rifampin | Care and treatment | Tuberculosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights